市场调查报告书
商品编码
1500567
输尿管镜市场:按类型、目的、应用、最终用户分类 - 全球预测 2024-2030Ureteroscope Market by Type (Flexible Ureteroscopes, Rigid Ureteroscopes, Semirigid Ureteroscopes), Usage (Multi-Use, Single-Use/Disposable), Application, End User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年输尿管镜市场规模为11亿美元,预计2024年将达11.6亿美元,2030年将达16.4亿美元,复合年增长率为5.77%。
输尿管镜是一种细长的管状医疗器械,具有照明和影像处理功能,设计用于输尿管的诊断和治疗检查,输尿管将尿液从肾臟输送到膀胱。这种专用的内视镜小心地插入尿道,穿过膀胱,最后插入输尿管。其主要功能包括肾结石、输尿管狭窄和肿瘤等输尿管疾病的识别和治疗。输尿管镜检查对于促进微创手术至关重要,可以在输尿管内进行直接可视化、切片检查和治疗,而无需大范围的手术切口。日益增长的老年人口(更容易患泌尿器官系统疾病)以及全球肾结石发病率的增加正在推动输尿管镜检查的需求。然而,先进输尿管镜的高成本限制了它们的承受能力和采用,特别是在成本敏感的市场。然而,开拓具有卓越视觉化功能(包括 3D 影像和扩增实境引导)的输尿管镜以提高手术精度可能代表着市场成长的机会。
主要市场统计 | |
---|---|
基准年[2023] | 11亿美元 |
预测年份 [2024] | 11.6亿美元 |
预测年份 [2030] | 16.4亿美元 |
复合年增长率(%) | 5.77% |
区域洞察
由于尿道结石和其他泌尿系统疾病的盛行率不断增加,美洲输尿管镜市场的特征是对输尿管软镜和硬性输尿管镜的需求量很大。美国因其强大的医疗基础设施、先进技术和高昂的医疗费用而领先市场规模。此外,该地区还有许多主要製造商,增加了获得最新输尿管镜型号的机会。政府透过采用基于价值的采购模式来减少医疗保健支出,这推动了对具有成本效益的高品质输尿管镜的需求。欧洲、中东和非洲地区为输尿管镜提供了多样化的市场环境,在先进的医疗保健系统和强劲的医疗保健支出的推动下,欧洲在市场采用率方面处于领先地位,尤其是在德国、法国和英国等国。另一方面,中东和非洲市场仍在发展中,成长受到医疗基础设施有限和医疗费用低廉的限制。也就是说,中东医疗保健提供者对采用更新的输尿管镜技术的兴趣很大,这表明潜在的市场成长潜力。欧洲的监管政策和医疗改革也影响先进输尿管镜设备的引进,重点在于病人安全和成本效率。在中国、印度和日本等国家医疗基础设施的快速发展和医疗成本不断上升的推动下,亚太地区的输尿管镜检查呈现出有利的情况。该地区的肾结石和其他泌尿系统疾病正在迅速增加,这推动了对输尿管镜的需求。然而,该地区一些经济体的成本敏感性也反映了对负担得起的医疗设备的需求。因此,随着全球和区域製造商专注于开发具有成本效益且技术先进的输尿管镜以满足不断变化的医疗保健需求,竞争格局正在改变。
FPNV定位矩阵
FPNV定位矩阵对于评估供应商在输尿管镜市场的定位至关重要。此矩阵提供了对供应商的全面评估,并检查了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果,供应商被分为代表其成功程度的四个像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对输尿管镜市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献,您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他关键指标。此外,该分析还提供了对该行业竞争性质的宝贵见解,包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息,供应商可以做出更明智的决策并製定有效的策略,以在市场竞争中保持领先地位。
策略分析与建议
策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对输尿管镜市场目前地位的全面评估使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析,以确定核心优势和需要改进的领域。
[180 Pages Report] The Ureteroscope Market size was estimated at USD 1.10 billion in 2023 and expected to reach USD 1.16 billion in 2024, at a CAGR 5.77% to reach USD 1.64 billion by 2030.
A ureteroscope is a thin, tube-like medical instrument equipped with lighting and imaging capabilities, designed for the diagnostic and therapeutic examination of the ureter for conveying urine from the kidney to the bladder. This specialized scope is carefully inserted into the urethra, navigated through the bladder, and eventually into the ureter. Its primary functions include the identification and management of ureteral conditions such as kidney stones, ureteral strictures, and tumors. Ureteroscopes are pivotal in facilitating minimally invasive procedures, allowing for direct visualization, biopsy, and treatment within the urinary tract without the need for extensive surgical incisions. An increasing elderly population prone to urological conditions coupled with a growing incidence of kidney stones worldwide drives demand for ureteroscopy procedures. However, the high cost of advanced ureteroscopes limits their affordability and adoption, particularly in cost-sensitive markets. Nevertheless, developing ureteroscopes with superior visualization capabilities, including 3-D imaging and augmented reality guidance, to improve procedural accuracy may provide an opportunistic landscape for market growth.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 1.10 billion |
Estimated Year [2024] | USD 1.16 billion |
Forecast Year [2030] | USD 1.64 billion |
CAGR (%) | 5.77% |
Regional Insights
The ureteroscope market in the Americas is characterized by high demand for both flexible and rigid ureteroscopes, spurred by a growing prevalence of urolithiasis and other urological conditions. The United States leads in terms of market size, attributed to strong healthcare infrastructure, availability of advanced technology, and significant health expenditure. Moreover, the region hosts numerous key manufacturers, enhancing access to the latest ureteroscope models. Government initiatives aimed at reducing healthcare expenditure through the adoption of value-based procurement models are driving demand for cost-effective and high-quality ureteroscopes. The EMEA region shows a diverse market landscape for ureteroscopes, with Europe leading in terms of market adoption rates, driven by advanced healthcare systems and robust healthcare spending, particularly in countries including Germany, France, and the UK. The market in the Middle East and Africa, however, is still developing, with growth restrained by limited healthcare infrastructure and lower healthcare expenditure. Nevertheless, there's a notable interest in adopting newer ureteroscopic technologies among healthcare providers in the Middle East, indicating potential market growth. Regulatory policies and healthcare reforms across Europe are also influencing the uptake of advanced ureteroscopic devices, focusing on patient safety and cost-efficiency. The Asia Pacific region shows an opportunistic landscape for ureteroscopes, driven by rapid healthcare infrastructure advancements and increasing healthcare expenditure in countries such as China, India, and Japan. The region is witnessing a surge in the prevalence of kidney stones and other urological conditions, which in turn is propelling the demand for ureteroscopes. However, the market is also characterized by a demand for affordable medical devices, given the cost-sensitive nature of several economies within the region. This has led to a competitive landscape where both global and regional manufacturers are focusing on developing cost-effective and technologically advanced ureteroscopes to cater to evolving healthcare needs.
Market Insights
The market dynamics represent an ever-changing landscape of the Ureteroscope Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Ureteroscope Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Ureteroscope Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Ambu receives European approval for ureteroscopy products
Ambu has received European regulatory approval for its ureteroscopy solution, supporting its expansion within the realm of urology procedures. This revolutionary product comprises the Ambu aScope 5 Uretero, a flexible, single-use ureteroscope crafted from eco-friendly Bio-ABS material, alongside the Ambu aBox 2, an advanced full-HD endoscopy system. The device aims to cater to the growing demand for single-use endoscopic solutions, providing high-quality imaging, durability, and maneuverability essential for addressing kidney and ureteral stones, ureteral strictures, and urothelial cancers. [Published On: 2023-11-29]
Capstone team enhances safety of ureteroscopy procedure
A recent initiative from Texas A&M University, called Infection Detection, has led to the development of a pioneering device aimed at early detection of urinary tract infections (UTIs) in patients undergoing ureteroscopy surgeries. This effort is sponsored by the medical technology firm Becton Dickinson (BD), which integrates seamlessly with current ureteroscopy procedures. This advances the diagnostic process significantly, reducing the standard detection time from days to potentially hours with further optimization. [Published On: 2023-07-20]
Boston Scientific Receives FDA Clearance for LithoVue Elite Single-Use Digital Flexible Ureteroscope System
Boston Scientific Corporation has received U.S. FDA 510(k) clearance for its innovative LithoVue Elite Single-Use Digital Flexible Ureteroscope System. This system stands out as the first ureteroscope equipped with a breakthrough feature allowing the real-time monitoring of intrarenal pressure during ureteroscopy procedures, a common but critical operation used in diagnosing and treating urinary tract issues, particularly kidney stones. With the integration of a built-in pressure sensor, the LithoVue Elite enables urologists to make immediate and informed decisions based on pressure changes, thus enhancing patient care by potentially reducing the likelihood of post-operative complications like systemic inflammatory response syndrome (SIRS), sepsis, and renal damage. [Published On: 2023-02-03]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Ureteroscope Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Ureteroscope Market, highlighting leading vendors and their innovative profiles. These include Advin Health Care, Becton, Dickinson and Company, Biomerics, Boston Scientific Corporation, Dornier MedTech GmbH, E.M.S. Electro Medical Systems S.A., Elmed Medical Systems, ERBE Elektromedizin GmbH, Karl Storz Medical AG, Obex, Olympus Corporation, OPCOM, OTU Medical Inc., PENTAX Medical, Prosurg Inc., Richard Wolf GmbH, Rocamed, SCHOLLY FIBEROPTIC GMBH, Stryker Corporation, and Vimex Sp. z o.o.
Market Segmentation & Coverage